Cardiol Therapeutics

CRDLNasdaq Canada Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$163.687 M

$1.42 +4.41%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

100,257,009

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#102Armata PharmaceuticalsARMP$172.9M
#103LENZ TherapeuticsLENZ$168.1M
#104Cardiol TherapeuticsCRDL$163.7M
#105Caribou BiosciencesCRBU$163.6M
#106Molecular PartnersMOLN$163.5M

Where these numbers come from

Share counts and financials for Cardiol Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.